Literature DB >> 12220027

Use of recombinant tissue-plasminogen activator in a dog with chylothorax secondary to catheter-associated thrombosis of the cranial vena cava.

Stuart P Bliss1, Susan K Bliss, H Jay Harvey.   

Abstract

A 4-year-old, castrated male Maltese developed cranial vena caval thrombosis and chylothorax following central venous catheterization for treatment of postoperative sepsis. Vena caval thrombolysis was attempted using recombinant human tissue-plasminogen activator (t-PA). Thrombolytic therapy led to an acute reduction in the size of the caval thrombus and was followed by prompt resolution of the chylothorax. Hemorrhage at the entry sites of a jugular catheter and esophagostomy tube placed at the time of treatment was a dose-limiting complication of t-PA therapy in this dog.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220027     DOI: 10.5326/0380431

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  7 in total

1.  Chylothorax associated with thrombosis of the cranial vena cava.

Authors:  Ameet Singh; Brigitte A Brisson
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

2.  Cranial vena cava syndrome secondary to cryptococcal mediastinal granuloma in a cat.

Authors:  Jo-Annie Letendre; Søren Boysen
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

3.  Concurrent cranial mediastinal Blastomyces granuloma and carcinoma with cranial vena caval syndrome in a dog.

Authors:  Natashia A Evans; Katrina R Viviano
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

4.  Diagnosis of aorto-iliac thrombosis in a quarter horse foal using Doppler ultrasound and nuclear scintigraphy.

Authors:  Vivienne E Duggan; Todd C Holbrook; Julie E Dechant; Margaret A Blaik; Jerry W Ritchey
Journal:  J Vet Intern Med       Date:  2004 Sep-Oct       Impact factor: 3.333

5.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

6.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics.

Authors:  Claire R Sharp; Marie-Claude Blais; Corrin J Boyd; Benjamin M Brainard; Daniel L Chan; Armelle de Laforcade; Robert Goggs; Julien Guillaumin; Alex Lynch; Erin Mays; Duana McBride; Tommaso Rosati; Elizabeth A Rozanski
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-07

7.  Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses.

Authors:  Wolfgang Bäumer; Gudrun M Herrling; Karsten Feige
Journal:  BMC Vet Res       Date:  2013-08-09       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.